ADDENDUM N° 2 TO EXCLUSIVE SUPPLY AGREEMENT for recombinant L-AsparaginaseExclusive Supply Agreement • July 10th, 2017 • Erytech Pharma S.A. • Biological products, (no disgnostic substances)
Contract Type FiledJuly 10th, 2017 Company IndustryERYTECH Pharma S.A, a company incorporated under the laws of the Republic of France (n° 479 560 013 RCS Lyon; VAT No. FR 10479560013)), having its registered head office at Bâtiment Adenine, 60 avenue Rockefeller, 69008 Lyon, France, represented by Mr Gil Beyen, Chief Executive Officer, and by Mr Jérôme Bailly, Qualified Person,
ADDENDUM N° 2 TO EXCLUSIVE SUPPLY AGREEMENTExclusive Supply Agreement • July 10th, 2017 • Erytech Pharma S.A. • Biological products, (no disgnostic substances)
Contract Type FiledJuly 10th, 2017 Company IndustryERYTECH Pharma S.A, a company incorporated under the laws of the Republic of France (n° 479 560 013 RCS Lyon; VAT No. FR 10479560013)), having its registered head office at Bâtiment Adenine, 60 avenue Rockefeller, 69008 Lyon, France, represented by Mr GIl Beyen, Chief Executive Officer, and by Mr Jérôme Bailly, Qualified Person,
ADDENDUM N°3 TO THE AGREEMENTAddendum • July 10th, 2017 • Erytech Pharma S.A. • Biological products, (no disgnostic substances)
Contract Type FiledJuly 10th, 2017 Company Industry• ERYTECH Pharma, S.A. with a share capital of 792 461,10 euros €, having its registered head office in Lyon 08, Bâtiment Adénine, 60 avenue Rockefeller, registered with the Trade and Companies Registry of Lyon under the number 479 560 013, represented by Mr Gil BEYEN, Chief Executive Officer, (“ERYTECH”)